Benzinga | Feb 11, 2021 04:09PM EST

Aytu BioScience Q2 Sales $15.15M Beat $12.25M Estimate

Aytu BioScience (NASDAQ:AYTU) reported quarterly sales of $15.15 million which beat the analyst consensus estimate of $12.25 million by 23.65 percent. This is a 377.07 percent increase over sales of $3.17 million the same period last year.